Key result
A literature review of 14 articles and 8 guidelines found prehospital clopidogrel to be safe, effective, and practical for the management of STEMI.
Why the study?
Prehospital clopidogrel use for STEMI varies among ambulance services, warranting an assessment of its pharmacological efficacy, safety, and role in standard practice.
Does prehospital administration of clopidogrel improve efficacy and safety in patients with STEMI?
Does prehospital administration of clopidogrel improve efficacy and safety in patients with STEMI?
Prehospital administration of clopidogrel is considered a safe and effective standard treatment for STEMI, though its superiority over newer agents like ticagrelor or prasugrel remains debated.
Answers are grounded in this paper and cite their sources.
Supports prehospital clopidogrel feasibility in STEMI; leaves open comparative efficacy versus newer P2Y12 inhibitors.
Clopidogrel is an anticoagulant commonly used in the prehospital environment for the management of ST-elevation myocardial infarction (STEMI). Some ambulance services have incorporated this into their treatment regimens; however, others hold a variety of alternative pharmacological interventions. This study examines and determine the pharmacological efficacy and safety of clopidogrel in the management of patients with STEMI and assess whether ambulance services should use the drug as part of standard practice. A literature review was conducted to identify articles relating to the administration of clopidogrel in the prehospital setting. Fourteen peer-reviewed journal articles and eight clinical practice guidelines from international ambulance services were included in this review. According to this review, clopidogrel has been deemed safe, effective and practical for widespread use in the prehospital environment for the management of STEMI. However, some disagreement has arisen over whether clopidogrel is a more favourable anticoagulant than ticagrelor and prasugrel. Anticoagulants such as clopidogrel should be strongly considered as a standard treatment regimen in the prehospital management of STEMI across international jurisdictions.
No takes yet. Share an insight, caveat, or question.
Hollier et al. (2021) conducted a review in ST-elevation myocardial infarction (STEMI). Clopidogrel was evaluated on Pharmacological efficacy and safety. A literature review of 14 articles and 8 guidelines found prehospital clopidogrel to be safe, effective, and practical for the management of STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: